Literature DB >> 8799067

Is this finding relevant? Generalisation and epidemiology.

A L Ponsonby1, T Dwyer, D Couper.   

Abstract

The decision about whether the findings from analytical epidemiological studies can be extrapolated to another setting is an important one. We discuss some of the issues involved in the process of generalisation. A critical systematic qualitative approach should be used. This involves an assessment of the internal validity of the study and of the nature of the study base. The study subject matter and choice of epidemiologic measure should be considered. A study base similar to the target population is essential if the study is descriptive or if there is concern about effect modifiers whose effects cannot be predicted. In addition, data from quantitative tests of study findings in different populations should be considered.

Mesh:

Year:  1996        PMID: 8799067     DOI: 10.1111/j.1467-842x.1996.tb01336.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  14 in total

1.  Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs.

Authors:  Nicole M Mealing; Emily Banks; Louisa R Jorm; David G Steel; Mark S Clements; Kris D Rogers
Journal:  BMC Med Res Methodol       Date:  2010-04-01       Impact factor: 4.615

2.  Home and community care services: a major opportunity for preventive health care.

Authors:  Louisa R Jorm; Scott R Walter; Sanja Lujic; Julie E Byles; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-05-22       Impact factor: 3.921

3.  Relationship of obesity to physical activity, domestic activities, and sedentary behaviours: cross-sectional findings from a national cohort of over 70,000 Thai adults.

Authors:  Emily Banks; Lynette Lim; Sam-Ang Seubsman; Chris Bain; Adrian Sleigh
Journal:  BMC Public Health       Date:  2011-10-04       Impact factor: 3.295

4.  Income-related inequalities in chronic conditions, physical functioning and psychological distress among older people in Australia: cross-sectional findings from the 45 and up study.

Authors:  Rosemary J Korda; Ellie Paige; Vasoontara Yiengprugsawan; Isabel Latz; Sharon Friel
Journal:  BMC Public Health       Date:  2014-07-22       Impact factor: 3.295

5.  Sociodemographic and health characteristics, rather than primary care supply, are major drivers of geographic variation in preventable hospitalizations in Australia.

Authors:  Michael O Falster; Louisa R Jorm; Kirsty A Douglas; Fiona M Blyth; Robert F Elliott; Alastair H Leyland
Journal:  Med Care       Date:  2015-05       Impact factor: 2.983

6.  Timing of urbanisation and cardiovascular risks in Thailand: evidence from 51 936 members of the thai cohort study, 2005-2009.

Authors:  Jiaying Zhao; Sam-Ang Seubsman; Adrian Sleigh; The Thai Cohort Study Team
Journal:  J Epidemiol       Date:  2014-07-19       Impact factor: 3.211

7.  Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data.

Authors:  Louisa R Jorm; Leah C Shepherd; Kris D Rogers; Fiona M Blyth
Journal:  BMC Health Serv Res       Date:  2012-08-18       Impact factor: 2.655

8.  High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level.

Authors:  Danijela Gnjidic; David G Le Couteur; Sallie-Anne Pearson; Andrew J McLachlan; Rosalie Viney; Sarah N Hilmer; Fiona M Blyth; Grace Joshy; Emily Banks
Journal:  BMC Public Health       Date:  2013-02-07       Impact factor: 3.295

9.  Association of Continuity of Primary Care and Statin Adherence.

Authors:  James R Warren; Michael O Falster; Bich Tran; Louisa Jorm
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

10.  Health behaviours and potentially preventable hospitalisation: a prospective study of older Australian adults.

Authors:  Bich Tran; Michael O Falster; Kirsty Douglas; Fiona Blyth; Louisa R Jorm
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.